JOHNSON KENNETH ERLAND has filed 12 insider transactions across 1 company since January 2022.
Most recent transaction: a tax payment of 15476 shares of Xeris Biopharma Holdings, Inc. ($XERS) on January 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 15476 | $3.56 | 346,288.0000 | 146,772,758 | 4.28% | 0.01% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 25842 | $3.56 | 320,446.0000 | 146,772,758 | 7.46% | 0.02% |
| Jan. 3, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 12401 | $3.61 | 361,764.0000 | 146,772,758 | 3.31% | 0.01% |
| Jan. 29, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 7497 | $2.11 | 440,443.0000 | 0 | 1.67% | 0.00% |
| Jan. 31, 2022 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 2307 | $2.11 | 438,136.0000 | 0 | 0.52% | 0.00% |
| Jan. 3, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 12400 | $1.12 | 425,736.0000 | 135,628,721 | 2.83% | 0.01% |
| Jan. 29, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 11029 | $1.26 | 414,707.0000 | 135,628,721 | 2.59% | 0.01% |
| Jan. 31, 2023 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 3393 | $1.24 | 411,314.0000 | 135,628,721 | 0.82% | 0.00% |
| Jan. 3, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 12400 | $2.24 | 398,914.0000 | 137,674,857 | 3.01% | 0.01% |
| Jan. 29, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 10747 | $2.66 | 388,167.0000 | 137,674,857 | 2.69% | 0.01% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | F | Common Stock | 15131 | $2.46 | 373,036.0000 | 137,674,857 | 3.90% | 0.01% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | JOHNSON KENNETH ERLAND | See Remarks | A | Common Stock | 175000 | $0.00 | 446,860.0000 | 137,674,857 | 64.37% | 0.13% |